Share Price and Basic Stock Data
Last Updated: February 10, 2026, 8:22 pm
| PEG Ratio | -10.82 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alkyl Amines Chemicals Ltd operates in the organic chemicals sector, primarily focusing on the production of amines and their derivatives. The company reported a share price of ₹1,556 and a market capitalization of ₹7,959 Cr. For the fiscal year ending March 2023, Alkyl Amines recorded sales of ₹1,683 Cr, reflecting a growth trajectory from ₹1,542 Cr in the previous year. However, the company’s revenue is projected to decline to ₹1,441 Cr in March 2024 before rebounding to ₹1,572 Cr in March 2025. Quarterly sales figures show fluctuations, with the highest quarterly sales of ₹412 Cr reported in March 2023, followed by a decrease to ₹352 Cr in September 2023. This indicates a cyclical pattern in demand, which may be influenced by broader economic conditions or sector-specific factors. The company’s consistent historical performance, with sales growing from ₹446 Cr in March 2014 to the latest figures, underlines its solid market position amidst a competitive landscape.
Profitability and Efficiency Metrics
Alkyl Amines reported a net profit of ₹182 Cr for the trailing twelve months, with a profit margin of approximately 11.7%. This profit reflects a decline from ₹229 Cr in March 2022, indicating a challenging operating environment. The company’s operating profit margin (OPM) stood at 18% for the latest reporting period, which is considered moderate compared to industry norms. The return on equity (ROE) was reported at 14.0%, while return on capital employed (ROCE) stood at 18.7%. These figures suggest that Alkyl Amines is efficiently utilizing its equity and capital to generate profits. Additionally, the interest coverage ratio (ICR) of 25.70x indicates strong financial health, allowing the company to comfortably meet its interest obligations. However, the cash conversion cycle (CCC) of 48 days raises concerns about liquidity management, as it suggests a longer time frame for converting investments into cash.
Balance Sheet Strength and Financial Ratios
As of the latest reports, Alkyl Amines maintains a robust balance sheet, with total assets amounting to ₹1,767 Cr and liabilities at ₹1,584 Cr. The company’s reserves have grown to ₹1,433 Cr, reflecting solid retained earnings and a strong equity base. Borrowings are minimal, recorded at ₹2 Cr, indicating a conservative approach to debt. The price-to-book value ratio (P/BV) is at 4.58x, suggesting that the stock may be trading at a premium compared to its book value, which could indicate investor confidence in future growth. The debt-to-equity ratio is low, reinforcing the company’s financial stability. Moreover, the efficiency ratios such as the operating profit margin (OPM) and return on capital employed (ROCE) position Alkyl Amines favorably against typical sector averages, showcasing effective management in leveraging assets for profitability. However, the decline in net profit from previous years raises questions regarding sustainability and effective cost management.
Shareholding Pattern and Investor Confidence
Alkyl Amines has a diverse shareholding structure, with promoters holding 72.03% of the equity, demonstrating strong insider confidence in the company’s prospects. Institutional investors have a modest presence, with foreign institutional investors (FIIs) at 3.44% and domestic institutional investors (DIIs) at 2.88%. The public shareholding stands at 21.66%, with a total of 153,451 shareholders. This distribution indicates a stable ownership structure, which is essential for long-term strategic decisions. The slight increase in FII holdings from 2.69% in December 2022 to 3.44% by September 2025 reflects growing investor interest, potentially spurred by Alkyl Amines’ operational performance and market positioning. However, the gradual decline in public shareholding suggests a potential consolidation of shares, which could impact liquidity. The company’s ability to attract institutional investment is a positive sign, yet it must address the public’s concerns regarding profitability trends to maintain confidence.
Outlook, Risks, and Final Insight
The outlook for Alkyl Amines is cautiously optimistic, given its strong market presence and financial stability. However, the company faces several risks, including volatility in raw material prices and potential disruptions in global supply chains, which could impact production costs and margins. The projected decline in revenue for FY 2024 raises concerns about its ability to maintain growth momentum. Additionally, the fluctuating quarterly sales figures indicate a possible dependency on market conditions that could affect demand. To navigate these challenges, Alkyl Amines must focus on optimizing operational efficiency and enhancing product offerings to cater to evolving market needs. Should the company successfully implement strategic initiatives to improve profitability and manage costs, it may stabilize and even grow its market share in the competitive chemicals sector. Overall, while the company has strong fundamentals, addressing these risks will be crucial for sustaining investor confidence and driving future growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 55.3 Cr. | 155 | 437/135 | 129 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,229 Cr. | 9,119 | 14,250/7,772 | 52.3 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 28.6 Cr. | 95.5 | 286/73.0 | 14.2 | 26.9 | 1.05 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 194 Cr. | 242 | 435/163 | 10.8 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,717.75 Cr | 1,516.26 | 65.27 | 334.84 | 0.42% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 388 | 412 | 410 | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 | 389 | 354 |
| Expenses | 319 | 335 | 336 | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 | 319 | 287 |
| Operating Profit | 70 | 78 | 74 | 48 | 60 | 69 | 79 | 74 | 71 | 68 | 77 | 70 | 67 |
| OPM % | 18% | 19% | 18% | 14% | 19% | 19% | 20% | 18% | 19% | 18% | 19% | 18% | 19% |
| Other Income | 5 | 2 | 5 | 2 | 5 | 3 | 5 | 9 | 7 | 9 | 8 | 7 | 8 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 12 | 12 | 13 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Profit before tax | 63 | 67 | 66 | 36 | 46 | 53 | 66 | 64 | 59 | 59 | 66 | 59 | 57 |
| Tax % | 27% | 28% | 25% | 25% | 28% | 28% | 26% | 26% | 26% | 22% | 25% | 27% | 26% |
| Net Profit | 46 | 49 | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 |
| EPS in Rs | 8.94 | 9.52 | 9.74 | 5.33 | 6.54 | 7.52 | 9.56 | 9.28 | 8.56 | 9.00 | 9.67 | 8.40 | 8.26 |
Last Updated: February 6, 2026, 7:18 pm
Below is a detailed analysis of the quarterly data for Alkyl Amines Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 354.00 Cr.. The value appears to be declining and may need further review. It has decreased from 389.00 Cr. (Sep 2025) to 354.00 Cr., marking a decrease of 35.00 Cr..
- For Expenses, as of Dec 2025, the value is 287.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 319.00 Cr. (Sep 2025) to 287.00 Cr., marking a decrease of 32.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Sep 2025) to 67.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Dec 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Sep 2025) to 19.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Sep 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Sep 2025) to 57.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Dec 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Dec 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Sep 2025) to 42.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 8.26. The value appears to be declining and may need further review. It has decreased from 8.40 (Sep 2025) to 8.26, marking a decrease of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:40 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,572 | 1,552 |
| Expenses | 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,280 | 1,267 |
| Operating Profit | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 291 | 285 |
| OPM % | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% | 18% |
| Other Income | 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 30 | 31 |
| Interest | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 1 | 1 |
| Depreciation | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 | 72 |
| Profit before tax | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 249 | 244 |
| Tax % | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | 25% | |
| Net Profit | 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 186 | 182 |
| EPS in Rs | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 36.39 | 35.63 |
| Dividend Payout % | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% | 28% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 4.65% | 11.11% | 0.00% | 28.00% | 31.25% | 155.95% | 37.21% | -23.73% | 1.78% | -34.93% | 24.83% |
| Change in YoY Net Profit Growth (%) | 0.00% | 6.46% | -11.11% | 28.00% | 3.25% | 124.70% | -118.74% | -60.94% | 25.51% | -36.71% | 59.77% |
Alkyl Amines Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 10% |
| 3 Years: | 1% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 9% |
| 3 Years: | -11% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 21% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 4, 2025, 10:50 pm
Balance Sheet
Last Updated: February 1, 2026, 12:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,392 | 1,433 |
| Borrowings | 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 6 | 2 |
| Other Liabilities | 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 381 | 322 |
| Total Liabilities | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,767 |
| Fixed Assets | 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,044 | 1,039 |
| CWIP | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 52 | 76 |
| Investments | 2 | 2 | 2 | 1 | 1 | 1 | -0 | 30 | -0 | -0 | -0 | -0 | -0 |
| Other Assets | 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 693 | 651 |
| Total Assets | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,767 |
Below is a detailed analysis of the balance sheet data for Alkyl Amines Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,433.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,392.00 Cr. (Mar 2025) to 1,433.00 Cr., marking an increase of 41.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 322.00 Cr.. The value appears to be improving (decreasing). It has decreased from 381.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 59.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,767.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,789.00 Cr. (Mar 2025) to 1,767.00 Cr., marking a decrease of 22.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,039.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,044.00 Cr. (Mar 2025) to 1,039.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 24.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 651.00 Cr.. The value appears to be declining and may need further review. It has decreased from 693.00 Cr. (Mar 2025) to 651.00 Cr., marking a decrease of 42.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,767.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,789.00 Cr. (Mar 2025) to 1,767.00 Cr., marking a decrease of 22.00 Cr..
Notably, the Reserves (1,433.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -66.00 | -48.00 | -20.00 | -25.00 | -63.00 | -1.00 | 170.00 | 383.00 | 303.00 | 260.00 | 249.00 | 285.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 |
| Inventory Days | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 |
| Days Payable | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 | 80 |
| Cash Conversion Cycle | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 |
| Working Capital Days | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 26 | 35 | 28 | 47 | 42 |
| ROCE % | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% | 19% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund | 460,300 | 0.46 | 73.47 | N/A | N/A | N/A |
| Aditya Birla Sun Life Business Cycle Fund | 71,982 | 0.64 | 11.49 | N/A | N/A | N/A |
| Aditya Birla Sun Life Manufacturing Equity Fund | 57,147 | 0.83 | 9.12 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 14,952 | 0.07 | 2.39 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 5,812 | 0.01 | 0.93 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 98.71 | 42.22 | 32.36 | 25.41 | 24.53 |
| Diluted EPS (Rs.) | 98.44 | 42.10 | 32.36 | 25.41 | 24.53 |
| Cash EPS (Rs.) | 109.66 | 51.66 | 39.53 | 31.67 | 30.79 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 262.88 | 185.71 | 151.39 | 125.32 | 102.02 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 262.88 | 185.71 | 151.39 | 125.32 | 102.44 |
| Revenue From Operations / Share (Rs.) | 486.42 | 414.66 | 301.87 | 245.27 | 236.92 |
| PBDIT / Share (Rs.) | 129.11 | 81.65 | 58.94 | 47.16 | 45.83 |
| PBIT / Share (Rs.) | 115.93 | 70.22 | 50.69 | 40.17 | 39.51 |
| PBT / Share (Rs.) | 118.25 | 62.98 | 46.70 | 36.22 | 35.58 |
| Net Profit / Share (Rs.) | 96.48 | 40.22 | 31.28 | 24.67 | 24.48 |
| NP After MI And SOA / Share (Rs.) | 98.63 | 42.18 | 32.33 | 25.39 | 24.51 |
| PBDIT Margin (%) | 26.54 | 19.69 | 19.52 | 19.23 | 19.34 |
| PBIT Margin (%) | 23.83 | 16.93 | 16.79 | 16.37 | 16.67 |
| PBT Margin (%) | 24.30 | 15.18 | 15.47 | 14.76 | 15.01 |
| Net Profit Margin (%) | 19.83 | 9.70 | 10.36 | 10.05 | 10.33 |
| NP After MI And SOA Margin (%) | 20.27 | 10.17 | 10.71 | 10.35 | 10.34 |
| Return on Networth / Equity (%) | 37.51 | 22.71 | 21.35 | 20.25 | 24.02 |
| Return on Capital Employeed (%) | 37.58 | 27.83 | 22.04 | 22.65 | 28.29 |
| Return On Assets (%) | 25.69 | 11.29 | 10.17 | 9.91 | 12.03 |
| Long Term Debt / Equity (X) | 0.08 | 0.20 | 0.35 | 0.25 | 0.21 |
| Total Debt / Equity (X) | 0.08 | 0.34 | 0.48 | 0.39 | 0.47 |
| Asset Turnover Ratio (%) | 1.28 | 1.21 | 1.06 | 1.08 | 1.18 |
| Current Ratio (X) | 1.91 | 1.26 | 1.33 | 1.40 | 1.42 |
| Quick Ratio (X) | 1.37 | 0.83 | 0.85 | 0.70 | 0.93 |
| Inventory Turnover Ratio (X) | 5.03 | 5.05 | 3.29 | 3.00 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 18.23 | 16.58 | 15.45 | 0.00 | 40.76 |
| Dividend Payout Ratio (CP) (%) | 16.08 | 13.04 | 12.31 | 0.00 | 32.41 |
| Earning Retention Ratio (%) | 81.77 | 83.42 | 84.55 | 0.00 | 59.24 |
| Cash Earning Retention Ratio (%) | 83.92 | 86.96 | 87.69 | 0.00 | 67.59 |
| Interest Coverage Ratio (X) | 25.70 | 11.29 | 14.76 | 11.95 | 11.64 |
| Interest Coverage Ratio (Post Tax) (X) | 18.74 | 6.56 | 8.83 | 7.25 | 7.22 |
| Enterprise Value (Cr.) | 2474.74 | 1821.38 | 1383.38 | 1017.13 | 733.06 |
| EV / Net Operating Revenue (X) | 2.49 | 2.15 | 2.25 | 2.03 | 1.52 |
| EV / EBITDA (X) | 9.39 | 10.93 | 11.50 | 10.56 | 7.84 |
| MarketCap / Net Operating Revenue (X) | 2.48 | 2.02 | 2.01 | 1.84 | 1.33 |
| Retention Ratios (%) | 81.76 | 83.41 | 84.54 | 0.00 | 59.23 |
| Price / BV (X) | 4.58 | 4.52 | 4.00 | 3.60 | 3.08 |
| Price / Net Operating Revenue (X) | 2.48 | 2.02 | 2.01 | 1.84 | 1.33 |
| EarningsYield | 0.08 | 0.05 | 0.05 | 0.05 | 0.07 |
After reviewing the key financial ratios for Alkyl Amines Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 20, the value is 98.71. This value is within the healthy range. It has increased from 42.22 (Mar 19) to 98.71, marking an increase of 56.49.
- For Diluted EPS (Rs.), as of Mar 20, the value is 98.44. This value is within the healthy range. It has increased from 42.10 (Mar 19) to 98.44, marking an increase of 56.34.
- For Cash EPS (Rs.), as of Mar 20, the value is 109.66. This value is within the healthy range. It has increased from 51.66 (Mar 19) to 109.66, marking an increase of 58.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 486.42. It has increased from 414.66 (Mar 19) to 486.42, marking an increase of 71.76.
- For PBDIT / Share (Rs.), as of Mar 20, the value is 129.11. This value is within the healthy range. It has increased from 81.65 (Mar 19) to 129.11, marking an increase of 47.46.
- For PBIT / Share (Rs.), as of Mar 20, the value is 115.93. This value is within the healthy range. It has increased from 70.22 (Mar 19) to 115.93, marking an increase of 45.71.
- For PBT / Share (Rs.), as of Mar 20, the value is 118.25. This value is within the healthy range. It has increased from 62.98 (Mar 19) to 118.25, marking an increase of 55.27.
- For Net Profit / Share (Rs.), as of Mar 20, the value is 96.48. This value is within the healthy range. It has increased from 40.22 (Mar 19) to 96.48, marking an increase of 56.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 98.63. This value is within the healthy range. It has increased from 42.18 (Mar 19) to 98.63, marking an increase of 56.45.
- For PBDIT Margin (%), as of Mar 20, the value is 26.54. This value is within the healthy range. It has increased from 19.69 (Mar 19) to 26.54, marking an increase of 6.85.
- For PBIT Margin (%), as of Mar 20, the value is 23.83. This value exceeds the healthy maximum of 20. It has increased from 16.93 (Mar 19) to 23.83, marking an increase of 6.90.
- For PBT Margin (%), as of Mar 20, the value is 24.30. This value is within the healthy range. It has increased from 15.18 (Mar 19) to 24.30, marking an increase of 9.12.
- For Net Profit Margin (%), as of Mar 20, the value is 19.83. This value exceeds the healthy maximum of 10. It has increased from 9.70 (Mar 19) to 19.83, marking an increase of 10.13.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is 20.27. This value exceeds the healthy maximum of 20. It has increased from 10.17 (Mar 19) to 20.27, marking an increase of 10.10.
- For Return on Networth / Equity (%), as of Mar 20, the value is 37.51. This value is within the healthy range. It has increased from 22.71 (Mar 19) to 37.51, marking an increase of 14.80.
- For Return on Capital Employeed (%), as of Mar 20, the value is 37.58. This value is within the healthy range. It has increased from 27.83 (Mar 19) to 37.58, marking an increase of 9.75.
- For Return On Assets (%), as of Mar 20, the value is 25.69. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.69, marking an increase of 14.40.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 19) to 0.08, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 20, the value is 0.08. This value is within the healthy range. It has decreased from 0.34 (Mar 19) to 0.08, marking a decrease of 0.26.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 1.28. It has increased from 1.21 (Mar 19) to 1.28, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 20, the value is 1.91. This value is within the healthy range. It has increased from 1.26 (Mar 19) to 1.91, marking an increase of 0.65.
- For Quick Ratio (X), as of Mar 20, the value is 1.37. This value is within the healthy range. It has increased from 0.83 (Mar 19) to 1.37, marking an increase of 0.54.
- For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.03. This value is within the healthy range. It has decreased from 5.05 (Mar 19) to 5.03, marking a decrease of 0.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 20, the value is 18.23. This value is below the healthy minimum of 20. It has increased from 16.58 (Mar 19) to 18.23, marking an increase of 1.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 20, the value is 16.08. This value is below the healthy minimum of 20. It has increased from 13.04 (Mar 19) to 16.08, marking an increase of 3.04.
- For Earning Retention Ratio (%), as of Mar 20, the value is 81.77. This value exceeds the healthy maximum of 70. It has decreased from 83.42 (Mar 19) to 81.77, marking a decrease of 1.65.
- For Cash Earning Retention Ratio (%), as of Mar 20, the value is 83.92. This value exceeds the healthy maximum of 70. It has decreased from 86.96 (Mar 19) to 83.92, marking a decrease of 3.04.
- For Interest Coverage Ratio (X), as of Mar 20, the value is 25.70. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.70, marking an increase of 14.41.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 18.74. This value is within the healthy range. It has increased from 6.56 (Mar 19) to 18.74, marking an increase of 12.18.
- For Enterprise Value (Cr.), as of Mar 20, the value is 2,474.74. It has increased from 1,821.38 (Mar 19) to 2,474.74, marking an increase of 653.36.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 2.49. This value is within the healthy range. It has increased from 2.15 (Mar 19) to 2.49, marking an increase of 0.34.
- For EV / EBITDA (X), as of Mar 20, the value is 9.39. This value is within the healthy range. It has decreased from 10.93 (Mar 19) to 9.39, marking a decrease of 1.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
- For Retention Ratios (%), as of Mar 20, the value is 81.76. This value exceeds the healthy maximum of 70. It has decreased from 83.41 (Mar 19) to 81.76, marking a decrease of 1.65.
- For Price / BV (X), as of Mar 20, the value is 4.58. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 19) to 4.58, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
- For EarningsYield, as of Mar 20, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 19) to 0.08, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alkyl Amines Chemicals Ltd:
- Net Profit Margin: 19.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 37.58% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.51% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 18.74
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.9 (Industry average Stock P/E: 65.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.83%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 401-407, Nirman Vyapar Kendra, Plot No. 10, Sector 17, New Mumbai Maharashtra 400703 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogesh M Kothari | Chairman & Managing Director |
| Mr. Kirat M Patel | Executive Director |
| Mr. Suneet Y Kothari | Executive Director |
| Mr. Premal N Kapadia | Non Executive Director |
| Mr. Rakesh S Goyal | Whole-Time Director (Operations) |
| Mrs. Leja S Hattiangadi | Independent Director |
| Mr. Chandrashekhar R Gupte | Independent Director |
| Mr. Ravi B Kapoor | Independent Director |
| Mr. Ashwin Ramanathan | Independent Director |
| Mrs. Bhavna G Doshi | Independent Director |
FAQ
What is the intrinsic value of Alkyl Amines Chemicals Ltd?
Alkyl Amines Chemicals Ltd's intrinsic value (as of 10 February 2026) is ₹1367.84 which is 13.76% lower the current market price of ₹1,586.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹8,110 Cr. market cap, FY2025-2026 high/low of ₹2,449/1,507, reserves of ₹1,433 Cr, and liabilities of ₹1,767 Cr.
What is the Market Cap of Alkyl Amines Chemicals Ltd?
The Market Cap of Alkyl Amines Chemicals Ltd is 8,110 Cr..
What is the current Stock Price of Alkyl Amines Chemicals Ltd as on 10 February 2026?
The current stock price of Alkyl Amines Chemicals Ltd as on 10 February 2026 is ₹1,586.
What is the High / Low of Alkyl Amines Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alkyl Amines Chemicals Ltd stocks is ₹2,449/1,507.
What is the Stock P/E of Alkyl Amines Chemicals Ltd?
The Stock P/E of Alkyl Amines Chemicals Ltd is 44.9.
What is the Book Value of Alkyl Amines Chemicals Ltd?
The Book Value of Alkyl Amines Chemicals Ltd is 282.
What is the Dividend Yield of Alkyl Amines Chemicals Ltd?
The Dividend Yield of Alkyl Amines Chemicals Ltd is 0.63 %.
What is the ROCE of Alkyl Amines Chemicals Ltd?
The ROCE of Alkyl Amines Chemicals Ltd is 18.7 %.
What is the ROE of Alkyl Amines Chemicals Ltd?
The ROE of Alkyl Amines Chemicals Ltd is 14.0 %.
What is the Face Value of Alkyl Amines Chemicals Ltd?
The Face Value of Alkyl Amines Chemicals Ltd is 2.00.